- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/35 - Parvoviridae, p. ex. virus de l'aleucémie féline, parvovirus humain
Détention brevets de la classe C12N 15/35
Brevets de cette classe: 269
Historique des publications depuis 10 ans
|
1
|
6
|
0
|
7
|
12
|
6
|
12
|
18
|
20
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4384 |
19 |
| The University of North Carolina at Chapel Hill | 2065 |
7 |
| The Children's Hospital of Philadelphia | 810 |
6 |
| Synplogen Co., Ltd. | 28 |
6 |
| Takara Bio Inc. | 228 |
5 |
| University of Iowa Research Foundation | 836 |
5 |
| FUJIFILM Corporation | 29817 |
4 |
| University of Florida Research Foundation, Inc. | 4084 |
4 |
| Genethon | 261 |
4 |
| University of Massachusetts | 2257 |
4 |
| Voyager Therapeutics, Inc. | 270 |
4 |
| Packgene Biotech Co., Ltd. | 15 |
4 |
| The Regents of the University of California | 20289 |
3 |
| Centre National de La Recherche Scientifique | 10693 |
3 |
| Deutsches Krebsforschungszentrum | 414 |
3 |
| Massachusetts Eye and Ear Infirmary | 388 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4444 |
3 |
| REGENXBIO Inc. | 247 |
3 |
| Schepens Eye Research Institute | 65 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2911 |
3 |
| Autres propriétaires | 173 |